Ivermectin and Others Flunk Severe COVID-19 Study, Vaccine Development Lawsuits Mount

A controlled trial evaluating ivermectin and two other generic drugs against severe COVID-19 generated data showing their overall ineffectiveness.

A study published in The New England Journal of Medicine evaluated whether any of three common generic drugs - fluvoxamine for depression, ivermectin for parasites and metformin, commonly used to prevent type 2 diabetes, could prevent severe COVID-19. In the end, none of the drugs were found to be effective.